Antibodies to lactobacilli and bifidobacteria in young children with different propensity to develop islet autoimmunity

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Talja, Ija ^a   Kubo, Anna Liisa ^a   Veijola, Riitta ^b   Knip, Mikael ^c,d,e   Simell, Olli ^f   Ilonen, Jorma ^f,g   Vähä Mäkilä, Mari ^f   Sepp, Epp ^a   Mikelsaar, Marika ^a   Utt, Meeme ^a   Uibo, Raivo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e FOLKHÄLSAN RESEARCH CENTER   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BACTERIAL CELL; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM LONGUM; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMMENSAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; ISLET AUTOIMMUNITY; LACTOBACILLUS RHAMNOSUS; MALE; ONSET AGE; PANCREAS ISLET; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; BIFIDOBACTERIUM; IMMUNOLOGY; INTESTINE; LACTOBACILLUS; MICROBIOLOGY; PRESCHOOL CHILD;

ANTIBODIES, BACTERIAL; AUTOIMMUNITY; BACTERIAL PROTEINS; BIFIDOBACTERIUM; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTESTINES; ISLETS OF LANGERHANS; LACTOBACILLUS; MALE;

EID: 84896980701     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/325938     Document Type: Article

References (28)

1. Taplin C., Barker J., Autoantibodies in type 1 diabetes. Autoimmunity 2008 41 1 11 18 2-s2.0-38049036388 10.1080/08916930701619169
2. Vehik K., Haller M. J., Beam C. A., Schatz D. A., Wherrett D. K., Sosenko J. M., Krischer J. P., Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood. Diabetes Care 2011 34 2 358 362 2-s2.0-79951713180 10.2337/dc10-1494
3. Knip M., Korhonen S., Kulmala P., Veijola R., Reunanen A., Raitakari O. T., Viikari J., Åkerblom H. K., Prediction of type 1 diabetes in the general population. Diabetes Care 2010 33 6 1206 1212 2-s2.0-77956089036 10.2337/dc09-1040
4. Salminen K., Sadeharju K., Lönnrot M., Vähäsalo P., Kupila A., Korhonen S., Ilonen J., Simell O., Knip M., Hyöty H., Enterovirus infections are associated with the induction of β -cell autoimmunity in a prospective birth cohort study. Journal of Medical Virology 2003 69 1 91 98 2-s2.0-0037211477 10.1002/jmv.10260 (Pubitemid 35403659)
5. Wahlberg J., Fredriksson J., Nikolic E., Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children. Pediatric Diabetes 2005 6 4 199 205 2-s2.0-29544445389 10.1111/j.1399-543X.2005. 00129.x (Pubitemid 43013627)
6. Borchers A. T., Uibo R., Gershwin M. E., The geoepidemiology of type 1 diabetes. Autoimmunity Reviews 2010 9 5 A355 A365 2-s2.0-77649236513 10.1016/j.autrev.2009.12.003
7. Schiffrin E. J., Blum S., Interactions between the micrbiota and the intestinal mucosa. European Journal of Clinical Nutrition 2002 56 560 564
8. He F., Ouwehand A. C., Isolauri E., Hashimoto H., Benno Y., Salminen S., Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunology and Medical Microbiology 2001 30 1 43 47 2-s2.0-0035134821 10.1016/S0928-8244(00)00232-7 (Pubitemid 32145003)
9. Furrie E., Probiotics and allergy. Proceedings of the Nutrition Society 2005 64 4 465 469 2-s2.0-28244436213 10.1079/PNS2005466 (Pubitemid 41705446)
10. Sjögren Y. M., Tomicic S., Lundberg A., Böttcher M. F., Björkstén B., Sverremark-Ekström E., Jenmalm M. C., Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses: gut microbiota and immune responses. Clinical and Experimental Allergy 2009 39 12 1842 1851 2-s2.0-72449145776 10.1111/j.1365-2222.2009.03326. x
11. Hörmannsperger G., Haller D., Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. International Journal of Medical Microbiology 2010 300 1 63 73 2-s2.0-71649089263 10.1016/j.ijmm.2009.08.006
12. Ouwehand A. C., Isolauri E., He F., Hashimoto H., Benno Y., Salminen S., Differences in Bifidobacterium flora composition in allergic and healthy infants. Journal of Allergy and Clinical Immunology 2001 108 1 144 145 2-s2.0-0034923958 (Pubitemid 32662250)
13. Štšepetova J., Sepp E., Julge K., Vaughan E., Mikelsaar M., De Vos W. M., Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunology and Medical Microbiology 2007 51 2 260 269 2-s2.0-35148817370 10.1111/j.1574-695X.2007.00306.x (Pubitemid 47547504)
14. Sjögren Y. M., Jenmalm M. C., Böttcher M. F., Björkstén B., Sverremark-Ekström E., Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clinical and Experimental Allergy 2009 39 4 518 526 2-s2.0-62449165965 10.1111/j.1365-2222. 2008.03156.x
15. Takahashi N., Kitazawa H., Iwabuchi N., Xiao J. Z., Miyaji K., Iwatsuki K., Saito T., Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clinical and Experimental Immunology 2006 145 1 130 138 2-s2.0-33745180845 10.1111/j.1365-2249.2006.03111. x (Pubitemid 43893942)
16. Medina M., Izquierdo E., Ennahar S., Sanz Y., Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clinical and Experimental Immunology 2007 150 3 531 538 2-s2.0-36049010630 10.1111/j.1365-2249.2007.03522. x (Pubitemid 350098744)
17. Hart A. L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., Campieri M., Kamm M. A., Knight S. C., Stagg A. J., Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004 53 11 1602 1609 2-s2.0-7244226119 10.1136/gut.2003.037325 (Pubitemid 39434103)
18. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001 357 9262 1076 1079 2-s2.0-0035820307 10.1016/S0140-6736(00)04259-8 (Pubitemid 32322538)
19. Yan F., Cao H., Cover T. L., Washington M. K., Shi Y., Liu L., Chaturvedi R., Peek R. M. Jr., Wilson K. T., Polk D. B., Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. Journal of Clinical Investigation 2011 121 6 2242 2253 2-s2.0-79957907960 10.1172/JCI44031
20. Prangli A.-L., Utt M., Talja I., Sepp E., Mikelsaar M., Rajasalu T., Uibo O., Tillmann V., Uibo R., Antigenic proteins of Lactobacillus acidophilus that are recognised by serum IgG antibodies in children with type 1 diabetes and coeliac disease. Pediatric Allergy and Immunology 2010 21 4 e772 e779 2-s2.0-79952391372
21. Nilsson I., Kornilovs'ka I., Lindgren S., Ljungh Å., Wadström T., Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. Journal of Medical Microbiology 2003 52 11 949 953 2-s2.0-1542645911 10.1099/jmm.0.05344-0 (Pubitemid 38648133)
22. Macpherson A. J., Geuking M. B., Slack E., Hapfelmeier S., McCoy K. D., The habitat, double life, citizenship, and forgetfulness of IgA. Immunological Reviews 2012 245 1 132 146 2-s2.0-83655203111 10.1111/j.1600-065X.2011.01072.x
23. Aumeunier A., Grela F., Ramadan A., Van L. P., Bardel E., Alcala A. G., Jeannin P., Akira S., Bach J.-F., Thieblemont N., Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS ONE 2010 5 7 2-s2.0-77955369313 10.1371/journal.pone.0011484 e11484
24. López P., Gueimonde M., Margolles A., Suárez A., Distinct Bifidobacterium strains drive different immune responses in vitro. International Journal of Food Microbiology 2010 138 1-2 157 165 2-s2.0-76949083518 10.1016/j.ijfoodmicro.2009.12.023
25. Kramer D. R., Sutherland R. M., Bao S., Husband A. J., Cytokine mediated effects in mucosal immunity. Immunology and Cell Biology 1995 73 5 389 396 2-s2.0-0028875174
26. He F., Morita H., Hashimoto H., Hosoda M., Kurisaki J.-I., Ouwehand A. C., Isolauri E., Benno Y., Salminen S., Intestinal Bifidobacterium species induce varying cytokine production. Journal of Allergy and Clinical Immunology 2002 109 6 1035 1036 2-s2.0-0036279746 10.1067/mai.2002.124894 (Pubitemid 34634319)
27. Giongo A., Gano K. A., Crabb D. B., Mukherjee N., Novelo L. L., Casella G., Drew J. C., Ilonen J., Knip M., Hyöty H., Veijola R., Simell T., Simell O., Neu J., Wasserfall C. H., Schatz D., Atkinson M. A., Triplett E. W., Toward defining the autoimmune microbiome for type 1 diabetes. ISME Journal 2011 5 1 82 91 2-s2.0-78650616947 10.1038/ismej.2010.92
28. Brown C. T., Davis-Richardson A. G., Giongo A., Gano K. A., Crabb D. B., Mukherjee N., Casella G., Drew J. C., Ilonen J., Knip M., Hyöty H., Veijola R., Simell T., Simell O., Neu J., Wasserfall C. H., Schatz D., Atkinson M. A., Triplett E. W., Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 2011 6 10 2-s2.0-80054722148 10.1371/journal.pone.0025792 e25792